Page last updated: 2024-08-24

3-iodobenzylguanidine and Neutropenia

3-iodobenzylguanidine has been researched along with Neutropenia in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
He, H; Xu, Q; Yu, C	1
Campbell, K; Coleman, M; DuBois, SG; Edmondson, DA; Haas-Kogan, DA; Karski, EE; Kohlgruber, AC; Matthay, KK; Olow, A	1
Charron, M; DuBois, SG; Glidden, DV; Hawkins, R; Huberty, J; Maris, JM; Matthay, KK; Messina, J; Veatch, J	1
Cheng, SC; Hawkins, RA; Howard, JP; Huberty, JP; Kersun, LS; Maris, JM; Matthay, KK	1
Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D	1
Ablin, A; DeSantes, K; Hasegawa, B; Hattner, RS; Huberty, J; Matthay, KK; Price, D; Reynolds, CP; Seeger, RC; Weinberg, VK	1
Ackery, D; Fielding, S; Flower, MA; Kemshead, J; Lashford, LS; Lewis, IJ	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Neutropenia

Article	Year
The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis. BMC cancer, 2022, Feb-28, Volume: 22, Issue:1 Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Neuroendocrine Tumors; Neutropenia; Survival Rate; Treatment Outcome	2022

Trials

4 trial(s) available for 3-iodobenzylguanidine and Neutropenia

Article	Year
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jun-15, Volume: 22, Issue:12 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Transplantation, Autologous	2004
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3 Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine	2005
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Humans; Infant; Iodine Radioisotopes; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Transplantation, Autologous	1998
A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG). Progress in clinical and biological research, 1991, Volume: 366 Topics: 3-Iodobenzylguanidine; Anemia; Antineoplastic Agents; Child, Preschool; Drug Evaluation; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Neutropenia; Radiation Injuries; Radionuclide Imaging; Thrombocytopenia	1991

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Neutropenia

Article	Year
Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After International journal of radiation oncology, biology, physics, 2017, 10-01, Volume: 99, Issue:2 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Biomarkers; Child; Child, Preschool; Female; Humans; Male; Membrane Proteins; Neuroblastoma; Neutropenia; Pilot Projects; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals	2017
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma. Pediatric blood & cancer, 2005, Volume: 44, Issue:3 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anemia; Bone Marrow; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome	2005

Article

Year

Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After

International journal of radiation oncology, biology, physics, 2017, 10-01, Volume: 99, Issue:2

Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Biomarkers; Child; Child, Preschool; Female; Humans; Male; Membrane Proteins; Neuroblastoma; Neutropenia; Pilot Projects; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals

2017

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.

Pediatric blood & cancer, 2005, Volume: 44, Issue:3

Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anemia; Bone Marrow; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome

2005